About
Adam Stern has built his career around his passion for innovation and his entrepreneurial spirit. Formerly Senior Managing Director at Spencer Trask Ventures, Adam Stern has more than 25 years of venture capital and investment banking experience focusing primarily on the life science and technology sectors of the capital markets. Adam Stern has completed over 100 transactions throughout his career, including private placements, public offerings, and mergers and acquisitions, with an aggregate value in excess of a billion dollars. Adam Stern has led private and public financings for a wide variety of companies. Adam Stern currently serves as a Director of Dance Biopharm, Inc., and Matinas BioPharma Holdings, Inc.. He is a former Director of InVivo Therapeutics Holdings Corp., Organovo Holdings, Inc., Prolor Biotech, and Labstyle Innovations Corporation. In 2013, Prolor was acquired by OPKO Health, Inc. for over $500 million. Adam Stern was Senior Managing Director at Spencer Trask
Position in the VCSift Database
- • 1,305 investors hold the Chief Executive Officer role in VCSift. Adam Stern is one of them.
- • 10,621 investors are based in New York, New York, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- New York, US
Contact Information
Find more investors like Adam
Search Investors